New Idexx Panel Detects Canine Lymphoma
Idexx Laboratories has launched Cancer Dx, a first-of-its-kind diagnostic panel for the early detection of lymphoma in dogs. According to Idexx, the panel “can be added to panels for sick pets and integrated into annual wellness screenings for as low as $15, providing veterinarians in the U.S. with actionable results within two to three days.”
Elanco to Update Zenrelia Product Claims
Elanco Animal Health has publicly replied to a U.S. Food and Drug Administration warning letter regarding the company’s Zenrelia atopic dermatitis medication. The FDA accused Elanco of “false or misleading claims and representations about the safety and effectiveness of Zenrelia.” In response, Elanco stated: “We appreciate the FDA’s perspective and are working quickly to review and update Zenrelia promotional materials as appropriate.”
American Regent Offers Canine OA Protocol Guide
American Regent, the maker of Adequan Canine (polysulfated glycosaminoglycan), has issued a protocol guide for veterinarians who treat canine osteoarthritis. Learn more at bit.ly/4b5WFIW.
Congress Tackles Xylazine Issue Again
The American Veterinary Medical Association is applauding the reintroduction of the Combating Illicit Xylazine Act in the U.S. House and Senate. “The legislation would provide the U.S. Drug Enforcement Administration with tools to help address the illicit drug by scheduling xylazine as a Schedule III drug, ensure common veterinary uses of the drug remain legal, help maintain the availability of the drug on the market for veterinarians, and allow the DEA to track the legitimate supply,” the AVMA reported.
Purdue Administrator Joins AVMA
Dr. Jim Weisman, a Purdue University assistant dean, was named the American Veterinary Medical Association’s new chief of academic affairs, research and accreditation. He will oversee the Division of Education and Research.
Wanted: Best U.S. Veterinary Hospitals
USA Today is seeking nominations for a list of the nation’s best animal hospitals, a feature scheduled for publication this spring. The newspaper stated it “wants to highlight veterinarian hospitals that help animals thrive, and in turn, have a positive impact in the communities those pets call home.” Learn more at bit.ly/4hLzgza.
Vetscan Imagyst Does Even More
Zoetis Inc. unveiled AI Masses as a new Vetscan Imagyst capability. The feature uses artificial intelligence to analyze potential neoplastic cells in lymph nodes and subcutaneous lesions.
Virginia-Maryland Professor Wins Research Award
Dr. Kylene Kehn-Hall, a professor of virology at Virginia-Maryland College of Veterinary Medicine, won the 2024 Zoetis Award for Veterinary Research Excellence. According to Zoetis, Dr. Kehn-Hall’s lab “uses artificial intelligence to unlock the secrets of hemorrhagic fever viruses, starting with Rift Valley fever virus, a disease that threatens both livestock and human health.”
Ceva Unveils Alternative to Clavamox
Ceva Animal Health has introduced Kesium (amoxicillin and clavulanate potassium tablets), a generic bioequivalent to Zoetis-produced Clavamox chewable tablets. Chewable, pork-flavored Kesium is a broad-spectrum oral antibiotic for treating bacterial infections in dogs and cats.
Otto Releases Artificial Intelligence Tools
Otto has added a free feature, AI Suite, to the Otto Flow client engagement platform. The three core tools are AI Recap, for automatically recording and summarizing appointment notes; AI Memo, for capturing, transcribing and summarizing phone calls made through Otto; and AI Suggest, for suggested follow-up responses within the Flow platform.
29,000-Plus Attend VMX
VMX 2025 had record-breaking attendance of nearly 30,000 people. The annual conference, hosted by the North American Veterinary Community in Orlando, Florida, also featured a record 735 exhibits. Early bird registration for VMX 2026, scheduled for Jan. 17 to 21, is open at go.navc.com/VMX2026.
Aurora Offers Generic NSAID for Horses
Aurora Pharmaceutical has released EquiCoxib, an FDA-approved generic equivalent of Equioxx (firocoxib), a non-steroidal anti-inflammatory drug (NSAID) used for pain and inflammation associated with osteoarthritis in horses. Equioxx is a Boehringer Ingelheim product.